,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,topotecan group,paclitaxel,,,,
0,median time to progression,18.9 weeks ( range < 1 to 92.6+ weeks ; 25 % censored ),14.7 weeks ( range < 1 to 137.3+ weeks ; 12.3 % censored ),NR,NR,P = 0.076,NR
